Design and evaluation of a systemically active agent, fluconazole.
Richardson
K
K
Pfizer Central Research, Sandwich, Kent, England.
Cooper
K
K
Marriott
M S
MS
Tarbit
M H
MH
Troke
P F
PF
Whittle
P J
PJ
D000818:Animals; D000935:Antifungal Agents / Q000138:chemical synthesis*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D015195:Drug Design; D005260:Female; D015725:Fluconazole; D006801:Humans; D051379:Mice; D015394:Molecular Structure; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000627:therapeutic use
D000935:Antifungal Agents; D014230:Triazoles; D015725:Fluconazole